Eclipsebio Expands Intellectual Property Portfolio to Support New Product Suites Designed to Probe RNA Structure and Reveal Ribosome Occupancy and RNA Modifications
Eclipse Bioinnovations, Inc. (Eclipsebio), a leading RNA genomics company developing and commercializing novel, data-driven technologies that interrogate RNA, today announced the completion of exclusive and co-exclusive licenses for intellectual property (IP) related to RNA structure probing, ribosome occupancy, and RNA modifications.